NCT07211776 Phase 3 Active not recruiting
A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease Study sponsor: Zai Lab (Shanghai) Co., Ltd.
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2027-03-14 Estimated
Enrollment · participants 108 Actual
Source updated 2026-09-09 Last update listed in the registry record
Version history
Changes to this trial Last 12 months
Posted 2026-09-09 · 3 fields changed
Participant count type changed
Enrollment · participant count changed
− Before 99 participants (planned)
+ After 108 participants (actual)
Recruitment status changed
+ After Active not recruiting
Check registry source
Posted 2025-12-29 · 1 field changed
Recruitment status changed
− Before Not yet recruiting
Check registry source
This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology
Trial